Hans F. W. Hoogkamer, Senior Director, Strategic Portfolio Planning, Actelion Pharmaceuticals
Hans is Senior Director of Global Clinical Development Affairs at Actelion Pharmaceuticals ltd. In his current role, he has strategic responsibilities for all aspects of a drug’s life cycle including drug development and strategic marketing.
He is also a member of Actelion’s Portfolio group. Hans obtained his university degree in Bio-Pharmaceutical Sciences from the University of Leiden in the Netherlands. Hans has held various positions in international pharmaceutical industry, including Roche and Johnson&Johnson until joining Actelion in 2000.